Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2015, Article ID 731781, 7 pages
http://dx.doi.org/10.1155/2015/731781
Research Article

Serum miR-224 Reflects Stage of Hepatocellular Carcinoma and Predicts Survival

1Department of Integrative Medicine, Fudan University Shanghai Cancer Center, 270 Dongan Road, Shanghai 200032, China
2Department of Oncology, Shanghai Medical College, Fudan University, Shanghai 200032, China

Received 15 August 2014; Accepted 30 October 2014

Academic Editor: Mathew Coleman

Copyright © 2015 Li-ping Zhuang and Zhi-qiang Meng. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. D. P. Bartel, “MicrRNAs: genomics, biogensis, mechanism and function,” Cell, vol. 116, pp. 281–297, 2004. View at Google Scholar
  2. J. Krol, I. Loedige, and W. Filipowicz, “The widespread regulation of microRNA biogenesis, function and decay,” Nature Reviews Genetics, vol. 11, no. 9, pp. 597–610, 2010. View at Publisher · View at Google Scholar · View at Scopus
  3. G. A. Calin, C. Sevignani, C. D. Dumitru et al., “Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers,” Proceedings of the National Academy of Sciences of the United States of America, vol. 101, no. 9, pp. 2999–3004, 2004. View at Publisher · View at Google Scholar · View at Scopus
  4. A. Esquela-Kerscher and F. J. Slack, “Oncomirs—microRNAs with a role in cancer,” Nature Reviews Cancer, vol. 6, no. 4, pp. 259–269, 2006. View at Publisher · View at Google Scholar · View at Scopus
  5. S. Gounaris-Shannon and T. Chevassut, “The role of miRNA in haematological malignancy,” Bone Marrow Research, vol. 2013, Article ID 269107, 12 pages, 2013. View at Publisher · View at Google Scholar
  6. K. John, J. Wu, B. W. Lee, and C. S. Farah, “MicroRNAs head and neck cancer,” International Journal of Dentistry, vol. 2013, Article ID 650218, 12 pages, 2013. View at Publisher · View at Google Scholar
  7. L. Mulrane, S. F. McGee, W. M. Gallagher, and D. P. O'Connor, “miRNA dysregulation in breast cancer,” Cancer Research, vol. 73, no. 22, pp. 6554–6562, 2013. View at Publisher · View at Google Scholar · View at Scopus
  8. X. W. Wang, N. H. H. Heegaard, and H. Orum, “MicroRNAs in liver disease,” Gastroenterology, vol. 142, no. 7, pp. 1431–1443, 2012. View at Publisher · View at Google Scholar · View at Scopus
  9. J. Lu, G. Getz, E. A. Miska et al., “MicroRNA expression profiles classify human cancers,” Nature, vol. 435, no. 7043, pp. 834–838, 2005. View at Publisher · View at Google Scholar · View at Scopus
  10. S. Volinia, G. A. Calin, C.-G. Liu et al., “A microRNA expression signature of human solid tumors defines cancer gene targets,” Proceedings of the National Academy of Sciences of the United States of America, vol. 103, no. 7, pp. 2257–2261, 2006. View at Publisher · View at Google Scholar · View at Scopus
  11. X. Chen, Y. Ba, L. Ma et al., “Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases,” Cell Research, vol. 18, no. 10, pp. 997–1006, 2008. View at Publisher · View at Google Scholar · View at Scopus
  12. Y. Wang, H. C. Toh, P. Chow et al., “MicroRNA-224 is up-regulated in hepatocellular carcinoma through epigenetic mechanisms,” The FASEB Journal, vol. 26, no. 7, pp. 3032–3041, 2012. View at Publisher · View at Google Scholar · View at Scopus
  13. P.-J. Chen, S.-H. Yeh, W.-H. Liu et al., “Androgen pathway stimulates MicroRNA-216a transcription to suppress the tumor suppressor in lung cancer-1 gene in early hepatocarcinogenesis,” Hepatology, vol. 56, no. 2, pp. 632–643, 2012. View at Publisher · View at Google Scholar · View at Scopus
  14. P. Gao, C. C.-L. Wong, E. K.-K. Tung, J. M.-F. Lee, C.-M. Wong, and I. O.-L. Ng, “Deregulation of microRNA expression occurs early and accumulates in early stages of HBV-associated multistep hepatocarcinogenesis,” Journal of Hepatology, vol. 54, no. 6, pp. 1177–1184, 2011. View at Publisher · View at Google Scholar · View at Scopus
  15. Y. Zhang, S. Takahashi, A. Tasaka, T. Yoshima, H. Ochi, and K. Chayama, “Involvement of microRNA-224 in cell proliferation, migration, invasion, and anti-apoptosis in hepatocellular carcinoma,” Journal of Gastroenterology and Hepatology, vol. 28, no. 3, pp. 565–575, 2013. View at Publisher · View at Google Scholar · View at Scopus
  16. K. Yuki, S. Hirohashi, M. Sakamoto, T. Kanai, and Y. Shimosato, “Growth and spread of hepatocellular carcinoma. A review of 240 consecutive autopsy cases,” Cancer, vol. 66, no. 10, pp. 2174–2179, 1990. View at Google Scholar
  17. S. Cheng, M. Wu, H. Chen et al., “Tumor thrombus types influence the prognosis of hepatocellular carcinoma with the tumor thrombi in the portal vein,” Hepato-Gastroenterology, vol. 54, no. 74, pp. 499–502, 2007. View at Google Scholar · View at Scopus
  18. G.-Y. Chau, W.-Y. Lui, K.-L. King, and C.-W. Wu, “Evaluation of effect of hemihepatic vascular occlusion and the pringle maneuver during hepatic resection for patients with hepatocellular carcinoma and impaired liver function,” World Journal of Surgery, vol. 29, no. 11, pp. 1374–1383, 2005. View at Publisher · View at Google Scholar · View at Scopus
  19. J. Bruix and M. Sherman, “Management of hepatocellular carcinoma: an update,” Hepatology, vol. 53, no. 3, pp. 1020–1022, 2011. View at Publisher · View at Google Scholar · View at Scopus
  20. E. Giovannetti, N. Funel, G. J. Peters et al., “MicroRNA-21 in pancreatic cancer: correlation with clinical outcome and pharmacologic aspects underlying its role in the modulation of gemcitabine activity,” Cancer Research, vol. 70, no. 11, pp. 4528–4538, 2010. View at Publisher · View at Google Scholar · View at Scopus
  21. Z.-Y. Tang, “Hepatocellular carcinoma—cause, treatment and metastasis,” World Journal of Gastroenterology, vol. 7, no. 4, pp. 445–454, 2001. View at Google Scholar · View at Scopus
  22. C. K. Lindsay, C. C. Sinha, and U. P. Thorgeirsson, “Morphological study of vascular dissemination in a metastatic hepatocellular carcinoma model in the monkey,” Hepatology, vol. 26, no. 5, pp. 1209–1215, 1997. View at Publisher · View at Google Scholar · View at Scopus
  23. M. Mitsunobu, A. Toyosaka, T. Oriyama, E. Okamoto, and N. Nakao, “Intrahepatic metastases in hepatocellular carcinoma: the role of the portal vein as an efferent vessel,” Clinical & Experimental Metastasis, vol. 14, no. 6, pp. 520–529, 1996. View at Publisher · View at Google Scholar · View at Scopus
  24. J. Haybaeck, N. Zeller, and M. Heikenwalder, “The parallel universe: microRNAs and their role in chronic hepatitis, liver tissue damage and hepatocarcinogenesis,” Swiss Medical Weekly, vol. 141, Article ID w13287, 2011. View at Publisher · View at Google Scholar · View at Scopus
  25. S. Liu, W. Guo, J. Shi et al., “MicroRNA-135a contributes to the development of portal vein tumor thrombus by promoting metastasis in hepatocellular carcinoma,” Journal of Hepatology, vol. 56, no. 2, pp. 389–396, 2012. View at Publisher · View at Google Scholar · View at Scopus
  26. C.-M. Wong, C. C.-L. Wong, J. M.-F. Lee, D. N.-Y. Fan, S. L.-K. Au, and I. O.-L. Ng, “Sequential alterations of microrna expression in hepatocellular carcinoma development and venous metastasis,” Hepatology, vol. 55, no. 5, pp. 1453–1461, 2012. View at Publisher · View at Google Scholar · View at Scopus
  27. P. S. Mitchell, R. K. Parkin, E. M. Kroh et al., “Circulating microRNAs as stable blood-based markers for cancer detection,” Proceedings of the National Academy of Sciences of the United States of America, vol. 105, no. 30, pp. 10513–10518, 2008. View at Publisher · View at Google Scholar
  28. H. Schwarzenbach, N. Nishida, G. A. Calin, and K. Pantel, “Clinical relevance of circulating cell-free microRNAs in cancer,” Nature Reviews Clinical Oncology, vol. 11, no. 3, pp. 145–156, 2014. View at Publisher · View at Google Scholar · View at Scopus
  29. P. Friedl and S. Alexander, “Cancer invasion and the microenvironment: plasticity and reciprocity,” Cell, vol. 147, no. 5, pp. 992–1009, 2011. View at Publisher · View at Google Scholar · View at Scopus
  30. F. Balkwill, K. A. Charles, and A. Mantovani, “Smoldering and polarized inflammation in the initiation and promotion of malignant disease,” Cancer Cell, vol. 7, no. 3, pp. 211–217, 2005. View at Publisher · View at Google Scholar · View at Scopus
  31. P. Yang, Q.-J. Li, Y. Feng et al., “TGF-β-miR-34a-CCL22 signaling-induced treg cell recruitment promotes venous metastases of HBV-positive hepatocellular carcinoma,” Cancer Cell, vol. 22, no. 3, pp. 291–303, 2012. View at Publisher · View at Google Scholar · View at Scopus
  32. D.-X. Lin, Q.-Y. Zhang, X. Li, Q.-W. Ye, F. Lin, and L.-L. Li, “An aggressive approach leads to improved survival in hepatocellular carcinoma patients with portal vein tumor thrombus,” Journal of Cancer Research and Clinical Oncology, vol. 137, no. 1, pp. 139–149, 2011. View at Publisher · View at Google Scholar · View at Scopus
  33. D. Takizawa, S. Kakizaki, N. Sohara et al., “Hepatocellular carcinoma with portal vein tumor thrombosis: clinical characteristics, prognosis, and patient survival analysis,” Digestive Diseases and Sciences, vol. 52, no. 11, pp. 3290–3295, 2007. View at Publisher · View at Google Scholar · View at Scopus
  34. S.-N. Shen, L.-F. Wang, Y.-F. Jia, Y.-Q. Hao, L. Zhang, and H. Wang, “Upregulation of microRNA-224 is associated with aggressive progression and poor prognosis in human cervical cancer,” Diagnostic Pathology, vol. 8, no. 1, article 69, 2013. View at Publisher · View at Google Scholar · View at Scopus
  35. J. Boguslawska, A. Wojcicka, A. Piekielko-Witkowska, A. Master, and A. Nauman, “MiR-224 targets the 3′UTR of type 1 5′-iodothyronine deiodinase possibly contributing to tissue hypothyroidism in renal cancer,” PLoS ONE, vol. 6, no. 9, Article ID e24541, 2011. View at Publisher · View at Google Scholar · View at Scopus
  36. K. Mavridis, K. Stravodimos, and A. Scorilas, “Downregulation and prognostic performance of microRNA 224 expression in prostate cancer,” Clinical Chemistry, vol. 59, no. 1, pp. 261–269, 2013. View at Publisher · View at Google Scholar · View at Scopus
  37. C. Scisciani, S. Vossio, F. Guerrieri et al., “Transcriptional regulation of miR-224 upregulated in human HCCs by NFκB inflammatory pathways,” Journal of Hepatology, vol. 56, no. 4, pp. 855–861, 2012. View at Publisher · View at Google Scholar · View at Scopus